King Pharmaceuticals, Inc. is a vertically integrated pharmaceutical company that performs basic research and develops, manufactures, markets and sells branded prescription pharmaceutical products. It operates in four segments: branded prescription pharmaceuticals business, animal health business, Meridian auto-injector business and royalties. The Company’s wholly owned subsidiaries include Alpharma Inc., Meridian Medical Technologies, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., Parkedale Pharmaceuticals, Inc. and Monarch Pharmaceuticals Ireland Limited. The Company markets its branded prescription pharmaceutical products to general/family practitioners, internal medicine physicians, neurologists, pain specialists, surgeons and hospitals across the United States and in Puerto Rico. On December 29, 2008, King Pharmaceuticals, Inc. acquired Alpharma Inc.